German biopharmaceutical started phase 1 of clinical studies with CVnCoV in June 2020 at centers in Germany πŸ‡©πŸ‡ͺ and Belgium πŸ‡§πŸ‡ͺ.
Latin America - At the end of September 2020, clinical trial for phase 2 a in Peru πŸ‡΅πŸ‡ͺ and Panama πŸ‡΅πŸ‡¦ began.

Β· Β· Web Β· 0 Β· 1 Β· 0
Sign in to participate in the conversation

This is a brand new server run by the main developers of the project as a spin-off of 🐘 It is not focused on any particular niche interest - everyone is welcome as long as you follow our code of conduct!